NSE: ACUTAAS | BSE: 543349

Mid-range Performer

Download real time

1093.10 -0.10 (-0.01%)

79.93% Gain from 52W Low

103.4K NSE+BSE Volume

NSE 25 Jun, 2025 1:24 PM (IST)

8,949.1

Market Cap

Above industry Median

1.5

Beta 1Year

Very High Volatility

Acutaas Chemicals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ACUTAAS, BSE:543349 Acutaas Chemicals Ltd.

Search Inside the pdf :

Acutaas Chemicals Ltd.

07 May 2025

1093.10

-0.01%

Stronger margins and CDMO traction underpin EPS upgrade

Buy: Acutaas Chemicals Ltd.

KRChoksey

Ami Organics’ Q4FY25 revenue stood at INR 3,085 Mn, up 37.1% YoY (+12.2% QoQ), above our estimates (+9.7%), led by significant growth in Advanced Intermediates segment. EBITDA came in at INR 850 Mn., up by 96.8% YoY (+23.7.0% QoQ), above our estimates (+9.7%) due to better-than-expected revenue.

Acutaas Chemicals Ltd. is trading below its 30 day SMA of 1137.7

Acutaas Chemicals Ltd.

07 May 2025

1093.10

-0.01%

Ami Organics: Q4FY25 Result Review

Buy: Acutaas Chemicals Ltd.

IDBI Capital

Acutaas Chemicals Ltd. is trading below its 30 day SMA of 1137.7

Acutaas Chemicals Ltd.

29 Jan 2025

1093.10

-0.01%

Late stage CDMO projects to be key growth catalyst

Buy: Acutaas Chemicals Ltd.

Recommendation Target

KRChoksey

Ami Organics’ revenue beat our estimates significantly due to strong growth in Advanced Intermediates segment. EBITDA and Adj. PAT was well above our estimates due to better-than-expected gross profit and operating leverage.

Acutaas Chemicals Ltd. is trading above its 200 day SMA of 1051.5

Acutaas Chemicals Ltd.

30 Oct 2024

1093.10

-0.01%

Ami Organics: Q2FY25 Result Review

Buy: Acutaas Chemicals Ltd.

Recommendation Target

IDBI Capital

Acutaas Chemicals Ltd. has an average target of 1376.50 from 2 brokers.

Acutaas Chemicals Ltd.

30 Oct 2024

1093.10

-0.01%

Outlook remains strong with robust top-line growth and margin expansion

Accumulate: Acutaas Chemicals Ltd.

Target

KRChoksey

Ami Organics’ revenue beat our estimates significantly due to strong growth in Advanced Intermediates. This is reflected in EBITDA and Adj. PAT performance, which beat our estimates primarily due to lower-than-expected employee expenses.

Number of FII/FPI investors increased from 125 to 154 in Mar 2025 qtr.

Acutaas Chemicals Ltd.

21 Aug 2024

1093.10

-0.01%

Demand pickup in Advanced Intermediates segment will drive revenue growth

Accumulate: Acutaas Chemicals Ltd.

Target

KRChoksey

Ami Organics’ revenue missed our estimates due to a decline in price realization. EBITDA missed our estimates due to an increase in raw material costs and employee expenses.

Acutaas Chemicals Ltd. has an average target of 1376.50 from 2 brokers.

Acutaas Chemicals Ltd.

16 May 2024

1093.10

-0.01%

Continued improved utilisation to drive growth

Accumulate: Acutaas Chemicals Ltd.

Target

KRChoksey

Ami Organics’ revenue beat our estimate by 2.3% due to strong volume growths across both Advanced Intermediates and Specialty chemicals segments. The EBITDA beat our estimates by a strong 32.5% due to much lower operating expenses.